Skip to content
Dr. Sandra Banack pipetting samples in the Brain Chemistry Labs laboratory in Jackson, Wyoming

Prevention Diagnosis Treatment

Research

Our path began in Guam, with a question about why two remote villages suffered so much neurological disease. We discovered that a neurotoxin in traditional foods was produced by cyanobacteria. This led to a possible new drug, and a new miRNA test that could change how quickly patients get help.

Prevention Diagnosis Treatment
  1. 01

    Prevention

    An environmental toxin.

    We traced BMAA, a neurotoxin made by cyanobacteria, from the cycad roots of Guam into the brains of ALS and Alzheimer's patients. It slips into proteins in place of the amino acid L-serine and makes them misfold and tangle. Today we monitor it in the air over the Great Salt Lake and the waters of Florida.

    Cyanobacteria and BMAA
  2. 02

    Diagnose

    One blood draw.

    It can take around 12 months to get an ALS diagnosis. Our blood test is based on a unique genetic fingerprint that differentiates people with ALS from healthy controls. Similar tests for Parkinson's, Alzheimer's, and Multiple Sclerosis are under development.

    The ALS Test
  3. 03

    Treat

    A naturally occurring amino acid.

    In laboratory and animal studies, increasing L-serine prevented BMAA from being built into proteins. Our FDA-approved clinical trial of L-serine for Mild Cognitive Impairment at Houston Methodist is nearing completion, and separate Phase II trials will begin soon for ALS and Parkinson's disease.

    L-serine trials